{
    "clinical_study": {
        "@rank": "159748", 
        "arm_group": [
            {
                "arm_group_label": "Postmenopausal, topical vaginal cream", 
                "arm_group_type": "Experimental", 
                "description": "Postmenopausal participants randomized to topical vaginal cream containing estrogen or placebo for about one month's use prior to scheduled surgery."
            }, 
            {
                "arm_group_label": "Pre-menopausal, no topical vaginal cream", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "Our primary aim in the current study is to determine important tissue differences, including\n      muscle and connective tissue changes, between postmenopausal women and reproductive age\n      women with pelvic floor dysfunction to help develop targeted and noninvasive treatments."
        }, 
        "brief_title": "Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse", 
        "condition": "Pelvic Floor Disorders", 
        "condition_browse": {
            "mesh_term": [
                "Prolapse", 
                "Pelvic Organ Prolapse"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  21 to 70 years of age\n\n          -  Stage II or greater pelvic organ prolapse (POP)\n\n          -  Individuals electing surgery to treat their POP\n\n          -  Willing and able to comply with study procedures\n\n          -  Willing and able to provide written informed consent\n\n        Exclusion Criteria:\n\n          -  Contraindication for estrogen cream\n\n          -  Any medical condition that in the opinion of the investigator would place the subject\n             at increased risk for participation\n\n          -  History of connective tissue disease\n\n          -  Previous hysterectomy or pelvic organ prolapse surgery\n\n          -  Known allergic reaction to any agent required by the protocol\n\n          -  Use of hormone therapy in postmenopausal women in the last 90 days\n\n          -  Pregnant or lactating females\n\n          -  History of prior noncompliance or the presence or history of psychiatric condition\n             that would in the opinion of the investigator make it difficult for the subject to\n             comply with study procedures or follow instructions"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01886794", 
            "org_study_id": "13-114"
        }, 
        "intervention": {
            "arm_group_label": "Postmenopausal, topical vaginal cream", 
            "description": "Topical vaginal estrogen cream is commonly but not universally used to improve the health of vaginal tissue prior to surgery.  This study will provide data regarding estrogen effects for post-menopausal women undergoing pelvic organ prolapse.", 
            "intervention_name": "Topical Vaginal Estrogen Cream/placebo", 
            "intervention_type": "Drug", 
            "other_name": "Premarin, Estrace"
        }, 
        "intervention_browse": {
            "mesh_term": "Estrogens"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "pelvic floor dysfunction", 
            "pelvic organ prolapse", 
            "vaginal estrogen effects"
        ], 
        "lastchanged_date": "April 10, 2014", 
        "link": {
            "url": "http://www.utmbhealth.com/PelvicHealth"
        }, 
        "location": {
            "contact": {
                "email": "trmuir@utmb.edu", 
                "last_name": "Tristi Muir, MD", 
                "phone": "409-747-6625"
            }, 
            "facility": {
                "address": {
                    "city": "League City", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77573"
                }, 
                "name": "UTMB Speciality Care Center at Victory Lakes"
            }, 
            "investigator": [
                {
                    "last_name": "Kathleen L Vincent, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Erin Conroy, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Role of Hormonal Status on Vascularization and Vaginal Tissue in Women With Pelvic Organ Prolapse", 
        "overall_contact": {
            "email": "caderkow@utmb.edu", 
            "last_name": "Carrie Derkowski, BS", 
            "phone": "409-772-5164"
        }, 
        "overall_official": {
            "affiliation": "UTMB Galveston", 
            "last_name": "Tristi Muir, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Composite of vaginal wall inflammatory markers and macrocirculatory and microcirculatory flow on pelvic floor dysfunction", 
            "safety_issue": "No", 
            "time_frame": "1-month perioperative study"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01886794"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Composite of tissue matrix metalloproteinases, collagen/elastin structure, microvasculature and muscle thickness", 
            "safety_issue": "No", 
            "time_frame": "1-month perioperative study"
        }, 
        "source": "The University of Texas, Galveston", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The University of Texas, Galveston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}